Multi-layered regulation of intestinal antimicrobial defense

Cellular and Molecular Life Sciences

Volumn 65, Issue 19, 2008, Pages 3019-3027

  Mukherjee, S ^a   Vaishnava, S ^a   Hooper, L V ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

C type lectin; Cathelicidin; Defensin; Inflammatory bowel disease; Paneth cell

Indexed keywords

CATHELICIDIN; DEFENSIN; LECTIN; RIBONUCLEASE;

ANTIMICROBIAL ACTIVITY; CROHN DISEASE; DEGRANULATION; ENTERITIS; ENZYME ACTIVITY; GASTROINTESTINAL TRACT FUNCTION; HOMEOSTASIS; HOST RESISTANCE; HUMAN; IMMUNOREGULATION; INTESTINE CELL; INTESTINE EPITHELIUM; INTESTINE MUCOSA; MICROBIAL COMMUNITY; NONHUMAN; PANETH CELL; PATHOGENESIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; REGULATORY MECHANISM; REVIEW; TRANSCRIPTION REGULATION;

ANTI-INFECTIVE AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; CATHELICIDINS; EPITHELIAL CELLS; HUMANS; INTESTINAL MUCOSA; LECTINS, C-TYPE; RIBONUCLEASES;

BACTERIA (MICROORGANISMS); MAMMALIA;

EID: 53049087417     PISSN: 1420682X     EISSN: 15691632     Source Type: Journal    
DOI: 10.1007/s00018-008-8182-3     Document Type: Review

References (73)

1. Turnbaugh, P. J., Ley, R. E., Hamady, M., Fraser-Liggett, C. M., Knight, R. and Gordon, J. I. (2007) The human microbiome project. Nature 449, 804-810.
2. Gill, S. R., Pop, M., Deboy, R. T., Eckburg, P. B., Turnbaugh, P. J., Samuel, B. S., Gordon, J. I., Relman, D. A., Fraser-Liggett, C. M. and Nelson, K. E. (2006). Metagenomic analysis of the human distal gut microbiome. Science 312, 1355-1359.
3. Wostmann, B. S., Larkin, C., Moriarty, A. and Bruckner-Kardoss, E. (1983). Dietary intake, energy metabolism, and excretory losses of adult male germfree Wistar rats. Lab. Anim. Sci. 33, 46-50.
4. Hooper, L. V., Midtvedt, T. and Gordon, J. I. (2002). How host-microbial interactions shape the nutrient environment of the mammalian intestine. Annu. Rev. Nutr. 22, 283-307.
5. Xu, J., Bjursell, M. K., Himrod, J., Deng, S., Carmichael, L. K., Chiang, H. C., Hooper, L. V. and Gordon, J. I. (2003). A genomic view of the human-Bacteroides thetaiotaomicron symbiosis. Science 299, 2074-2076.
6. Sonnenburg, J. L., Xu, J., Leip, D. D., Chen, C. H., Westover, B. P., Weatherford, J., Buhler, J. D. and Gordon, J. I. (2005). Glycan foraging in vivo by an intestine-adapted bacterial symbiont. Science 307, 1955-1959.
7. Mazmanian, S. K., Liu, C. H., Tzianabos, A. O. and Kasper, D. L. (2005). An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell 122, 107-118.
8. Stappenbeck, T. S., Hooper, L. V. and Gordon, J. I. (2002). Developmental regulation of intestinal angiogenesis by indigenous microbes via Paneth cells. Proc. Natl. Acad. Sci. USA 99, 15451-15455.
9. Backhed, F., Ding, H., Wang, T., Hooper, L. V., Koh, G. Y., Nagy, A., Semenkovich, C. F. and Gordon, J. I. (2004). The gut microbiota as an environmental factor that regulates fat storage. Proc. Natl. Acad. Sci. USA 101, 15718-15723.
10. Eckburg, P. B., Bik, E. M., Bernstein, C. N., Purdom, E., Dethlefsen, L., Sargent, M., Gill, S. R., Nelson, K. E. and Relman, D. A. (2005). Diversity of the human intestinal microbial flora. Science 308, 1635-1638.
11. Palmer, C., Bik, E. M., Digiulio, D. B., Relman, D. A. and Brown, P. O. (2007). Development of the human infant intestinal microbiota. PLoS Biol. 5, e177.
12. Salzman, N. H., Underwood, M. A. and Bevins, C. L. (2007). Paneth cells, defensins, and the commensal microbiota: a hypothesis on intimate interplay at the intestinal mucosa. Semin. Immunol. 19, 70-83.
13. Ganz, T. (2004). Antimicrobial polypeptides. J. Leukoc. Biol. 75, 34-38.
14. Koprivnjak, T., Peschel, A., Gelb, M. H., Liang, N. S. and Weiss, J. P. (2002). Role of charge properties of bacterial envelope in bactericidal action of human group IIA phospholipase A2 against Staphylococcus aureus. J. Biol. Chem. 277, 47636-47644.
15. Beers, S. A., Buckland, A. G., Koduri, R. S., Cho, W., Gelb, M. H. and Wilton, D. C. (2002). The antibacterial properties of secreted phospholipases A2: a major physiological role for the group IIA enzyme that depends on the very high pI of the enzyme to allow penetration of the bacterial cell wall. J. Biol. Chem. 277, 1788-1793.
16. Harwig, S. S., Tan, L., Qu, X. D., Cho, Y., Eisenhauer, P. B. and Lehrer, R. I. (1995). Bactericidal properties of murine intestinal phospholipase A2. J. Clin. Invest. 95, 603-610.
17. Vadas, P., Browning, J., Edelson, J. and Pruzanski, W. (1993). Extracellular phospholipase A2 expression and inflammation: the relationship with associated disease states. J. Lipid. Mediat. 8, 1-30.
18. Brogden, K. A. (2005). Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat. Rev. Microbiol. 3, 238-250.
19. Selsted, M. E. and Ouellette, A. J. (2005). Mammalian defensins in the antimicrobial immune response. Nat. Immuno.l 6, 551-557.
20. Kagan, B. L., Selsted, M. E., Ganz, T. and Lehrer, R. I. (1990). Antimicrobial defensin peptides form voltage-dependent ion-permeable channels in planar lipid bilayer membranes. Proc. Natl. Acad. Sci. USA 87, 210-214.
21. Bechinger, B. and Lohner, K. (2006). Detergent-like actions of linear amphipathic cationic antimicrobial peptides. Biochim. Biophys. Acta. 1758, 1529-1539.
22. Huang, H.W. (2000). Action of antimicrobial peptides: two-state model. Biochemistry 39, 8347-8352.
23. Zasloff, M. (2002). Antimicrobial peptides of multicellular organisms. Nature 415, 389-395.
24. Salzman, N. H., Ghosh, D., Huttner, K. M., Paterson, Y. and Bevins, C. L. (2003). Protection against enteric salmonellosis in transgenic mice expressing a human intestinal defensin. Nature 422, 522-526.
25. Hornef, M. W., Putsep, K., Karlsson, J., Refai, E. and Andersson, M. (2004). Increased diversity of intestinal antimicrobial peptides by covalent dimer formation. Nat. Immunol. 5, 836-483.
26. O'Neil, D. A., Porter, E. M., Elewaut, D., Anderson, G. M., Eckmann, L., Ganz, T. and Kagnoff, M. F. (1999). Expression and regulation of the human β-defensins hBD-1 and hBD-2 in intestinal epithelium. J. Immunol. 163, 6718-6724.
27. Schutte, B. C., Mitros, J. P., Bartlett, J. A., Walters, J. D., Jia, H. P., Welsh, M. J., Casavant, T. L. and McCray, P. B., Jr. (2002). Discovery of five conserved β-defensin gene clusters using a computational search strategy. Proc. Natl. Acad. Sci. USA 99, 2129-2133.
28. Fahlgren, A., Hammarstrom, S., Danielsson, A. and Hammarstrom, M. L. (2003). Increased expression of antimicrobial peptides and lysozyme in colonic epithelial cells of patients with ulcerative colitis. Clin. Exp. Immunol. 131, 90-101.
29. Wehkamp, J., Fellermann, K., Herrlinger, K. R., Baxmann, S., Schmidt, K., Schwind, B., Duchrow, M., Wohlschlager, C., Feller, A. C. and Stange, E. F. (2002). Human β-defensin 2 but not β-defensin 1 is expressed preferentially in colonic mucosa of inflammatory bowel disease. Eur. J. Gastroenterol. Hepatol. 14, 745-752.
30. O'Neil, D. A., Cole, S. P., Martin-Porter, E., Housley, M. P., Liu, L., Ganz, T. and Kagnoff, M. F. (2000). Regulation of human β-defensins by gastric epithelial cells in response to infection with Helicobacter pylori or stimulation with interleukin-1. Infect. Immun. 68, 5412-5415.
31. Biragyn, A., Ruffini, P. A., Leifer, C. A., Klyushnenkova, E., Shakhov, A., Chertov, O., Shirakawa, A. K., Farber, J. M., Segal, D. M., Oppenheim, J. J. and Kwak, L. W. (2002). Toll-like receptor 4-dependent activation of dendritic cells by β-defensin 2. Science 298, 1025-1029.
32. Agerberth, B., Charo, J., Werr, J., Olsson, B., Idali, F., Lindbom, L., Kiessling, R., Jornvall, H., Wigzell, H. and Gudmundsson, G. H. (2000). The human antimicrobial and chemotactic peptides LL-37 and α-defensins are expressed by specific lymphocyte and monocyte populations. Blood 96, 3086-3093.
33. Romeo, D., Skerlavaj, B., Bolognesi, M. and Gennaro, R. (1988). Structure and bactericidal activity of an antibiotic dodecapeptide purified from bovine neutrophils. J Biol. Chem. 263, 9573-9575.
34. Hase, K., Eckmann, L., Leopard, J. D., Varki, N. and Kagnoff, M. F. (2002). Cell differentiation is a key determinant of cathelicidin LL-37/human cationic antimicrobial protein 18 expression by human colon epithelium. Infect. Immun. 70, 953-963.
35. Bals, R., Wang, X., Zasloff, M. and Wilson, J. M. (1998). The peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface. Proc. Natl. Acad. Sci. USA 95, 9541-9546.
36. Braff, M. H., Zaiou, M., Fierer, J., Nizet, V. and Gallo, R. L. (2005). Keratinocyte production of cathelicidin provides direct activity against bacterial skin pathogens. Infect. Immun. 73, 6771-6781.
37. Chromek, M., Slamova, Z., Bergman, P., Kovacs, L., Podracka, L., Ehren, I., Hokfelt, T., Gudmundsson, G. H., Gallo, R. L., Agerberth, B. and Brauner, A. (2006). The antimicrobial peptide cathelicidin protects the urinary tract against invasive bacterial infection. Nat. Med. 12, 636-641.
38. Bals, R. and Wilson, J. M. (2003). Cathelicidins-a family of multifunctional antimicrobial peptides. Cell. Mol. Life Sci. 60, 711-720.
39. Koczulla, R., von Degenfeld, G., Kupatt, C., Krotz, F., Zahler, S., Gloe, T., Issbrucker, K., Unterberger, P., Zaiou, M., Lebherz, C., Karl, A., Raake, P., Pfosser, A., Boekstegers, P., Welsch, U., Hiemstra, P. S., Vogelmeier, C., Gallo, R. L., Clauss, M. and Bals, R. (2003). An angiogenic role for the human peptide antibiotic LL-37/hCAP-18. J. Clin. Invest. 111, 1665-1672.
40. Davidson, D. J., Currie, A. J., Reid, G. S., Bowdish, D. M., MacDonald, K. L., Ma, R. C., Hancock, R. E. and Speert, D. P. (2004). The cationic antimicrobial peptide LL-37 modulates dendritic cell differentiation and dendritic cell-induced T cell polarization. J. Immunol. 172, 1146-1156.
41. Hooper, L. V., Stappenbeck, T. S., Hong, C. V. and Gordon, J. I. (2003). Angiogenins: a new class of microbicidal proteins involved in innate immunity. Nat. Immunol. 4, 269-273.
42. Harder, J. and Schroder, J. M. (2002). RNase 7, a novel innate immune defense antimicrobial protein of healthy human skin. J. Biol. Chem. 277, 46779-46784.
43. Rosenberg, H. F. (1995). Recombinant human eosinophil cationic protein. Ribonuclease activity is not essential for cytotoxicity. J. Biol. Chem. 270, 7876-7881.
44. Cash, H. L., Whitham, C. V., Behrendt, C. L. and Hooper, L. V. (2006). Symbiotic bacteria direct expression of an intestinal bactericidal lectin. Science 313, 1126-1130.
45. Christa, L., Carnot, F., Simon, M. T., Levavasseur, F., Stinnakre, M. G., Lasserre, C., Thepot, D., Clement, B., Devinoy, E. and Brechot, C. (1996). HIP/PAP is an adhesive protein expressed in hepatocarcinoma, normal Paneth, and pancreatic cells. Am. J. Physiol. 271, G993-1002.
46. Dieckgraefe, B. K., Crimmins, D. L., Landt, V., Houchen, C., Anant, S., Porche-Sorbet, R. and Ladenson, J. H. (2002). Expression of the regenerating gene family in inflammatory bowel disease mucosa: Reg Iα upregulation, processing, and antiapoptotic activity. J. Invest. Med. 50, 421-434.
47. Falk, P. G., Hooper, L. V., Midtvedt, T. and Gordon, J. I. (1998). Creating and maintaining the gastrointestinal ecosystem: what we know and need to know from gnotobiology. Microbiol. Mol. Biol. Rev. 62, 1157-1170.
48. Putsep, K., Axelsson, L. G., Boman, A., Midtvedt, T., Normark, S., Boman, H. G. and Andersson, M. (2000). Germ-free and colonized mice generate the same products from enteric prodefensins. J. Biol. Chem. 275, 40478-40482.
49. Hooper, L. V., Wong, M. H., Thelin, A., Hansson, L., Falk, P. G. and Gordon, J. I. (2001). Molecular analysis of commensal host-microbial relationships in the intestine. Science 291, 881-884.
50. Eckmann, L. (2004). Innate immunity and mucosal bacterial interactions in the intestine. Curr. Opin. Gastroenterol. 20, 82-88.
51. Ogura, Y., Lala, S., Xin, W., Smith, E., Dowds, T. A., Chen, F. F., Zimmermann, E., Tretiakova, M., Cho, J. H., Hart, J., Greenson, J. K., Keshav, S. and Nunez, G. (2003). Expression of NOD2 in Paneth cells: a possible link to Crohn's ileitis. Gut 52, 1591-1597.
52. Lala, S., Ogura, Y., Osborne, C., Hor, S. Y., Bromfield, A., Davies, S., Ogunbiyi, O., Nunez, G. and Keshav, S. (2003). Crohn's disease and the NOD2 gene: a role for paneth cells. Gastroenterology 125, 47-57.
53. Inohara, N., Ogura, Y., Fontalba, A., Gutierrez, O., Pons, F., Crespo, J., Fukase, K., Inamura, S., Kusumoto, S., Hashimoto, M., Foster, S. J., Moran, A. P., Fernandez-Luna, J. L. and Nunez, G. (2003). Host recognition of bacterial muramyl dipeptide mediated through NOD2: implications for Crohn's disease. J. Biol. Chem. 278, 5509-5512.
54. Girardin, S. E., Boneca, I. G., Viala, J., Chamaillard, M., Labigne, A., Thomas, G., Philpott, D. J. and Sansonetti, P. J. (2003). Nod2 is a general sensor of peptidoglycan through muramyl dipeptide(MDP) detection. J. Biol. Chem. 278, 8869-8872.
55. Akira, S., Uematsu, S. and Takeuchi, O. (2006). Pathogen recognition and innate immunity. Cell 124, 783-801.
56. Kobayashi, K. S., Chamaillard, M., Ogura, Y., Henegariu, O., Inohara, N., Nunez, G. and Flavell, R. A. (2005). Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science 307, 731-734.
57. Chung, W. O. and Dale, B. A. (2004). Innate immune response of oral and foreskin keratinocytes: utilization of different signaling pathways by various bacterial species. Infect. Immun. 72, 352-358.
58. Brandl, K., Plitas, G., Schnabl, B., Dematteo, R. P. and Pamer, E. G. (2007). MyD88-mediated signals induce the bactericidal lectin RegIIIγ and protect mice against intestinal Listeria monocytogenes infection. J. Exp. Med. 204, 1891-1900.
59. Rakoff-Nahoum, S. and Medzhitov, R. (2007). Regulation of spontaneous intestinal tumorigenesis through the adaptor protein MyD88. Science 317, 124-127.
60. Wilson, C. L., Ouellette, A. J., Satchell, D. P., Ayabe, T., Lopez-Boado, Y. S., Stratman, J. L., Hultgren, S. J., Matrisian, L. M. and Parks, W. C. (1999). Regulation of intestinal α-defensin activation by the metalloproteinase matrilysin in innate host defense. Science 286, 113-117.
61. Satchell, D. P., Sheynis, T., Shirafuji, Y., Kolusheva, S., Ouellette, A. J. and Jelinek, R. (2003). Interactions of mouse Paneth cell α-defensins and α-defensin precursors with membranes. Prosegment inhibition of peptide association with biomimetic membranes. J. Biol. Chem. 278, 13838-13846.
62. Ayabe, T., Satchell, D. P., Pesendorfer, P., Tanabe, H., Wilson, C. L., Hagen, S. J. and Ouellette, A. J. (2002). Activation of Paneth cell α-defensins in mouse small intestine. J. Biol. Chem. 277, 5219-5228.
63. Ghosh, D., Porter, E., Shen, B., Lee, S. K., Wilk, D., Drazba, J., Yadav, S. P., Crabb, J. W., Ganz, T. and Bevins, C. L. (2002). Paneth cell trypsin is the processing enzyme for human defensin-5. Nat. Immunol. 3, 583-590.
64. Cunliffe, R. N., Rose, F. R., Keyte, J., Abberley, L., Chan, W. C. and Mahida, Y. R. (2001). Human defensin 5 is stored in precursor form in normal Paneth cells and is expressed by some villous epithelial cells and by metaplastic Paneth cells in the colon in inflammatory bowel disease. Gut 48, 176-185.
65. Sorensen, O. E., Follin, P., Johnsen, A. H., Calafat, J., Tjabringa, G. S., Hiemstra, P. S. and Borregaard, N. (2001). Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3. Blood 97, 3951-3959.
66. Schutte, B. C. and McCray, P. B., Jr. (2002). β-Defensins in lung host defense. Annu. Rev. Physiol. 64, 709-748.
67. Ayabe, T., Satchell, D. P., Wilson, C. L., Parks, W. C., Selsted, M. E. and Ouellette, A. J. (2000). Secretion of microbicidal α-defensins by intestinal Paneth cells in response to bacteria. Nat. Immunol. 1, 113-118.
68. Sartor, R. B. (2001). Intestinal microflora in human and experimental inflammatory bowel disease. Curr. Opin. Gastroenterol. 17, 324-330.
69. Ogura, Y., Bonen, D. K., Inohara, N., Nicolae, D. L., Chen, F. F., Ramos, R., Britton, H., Moran, T., Karaliuskas, R., Duerr, R. H., Achkar, J. P., Brant, S. R., Bayless, T. M., Kirschner, B. S., Hanauer, S. B., Nunez, G. and Cho, J. H. (2001). A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 411, 603-606.
70. Li, J., Moran, T., Swanson, E., Julian, C., Harris, J., Bonen, D. K., Hedl, M., Nicolae, D. L., Abraham, C. and Cho, J. H. (2004). Regulation of IL-8 and IL-1β expression in Crohn's disease associated NOD2/CARD15 mutations. Hum. Mol. Genet. 13, 1715-1725.
71. Maeda, S., Hsu, L. C., Liu, H., Bankston, L. A., Iimura, M., Kagnoff, M. F., Eckmann, L. and Karin, M. (2005). Nod2 mutation in Crohn's disease potentiates NF-κB activity and IL-1β processing. Science 307, 734-738.
72. Wehkamp, J., Salzman, N. H., Porter, E., Nuding, S., Weichenthal, M., Petras, R. E., Shen, B., Schaeffeler, E., Schwab, M., Linzmeier, R., Feathers, R. W., Chu, H., Lima, H., Jr., Fellermann, K., Ganz, T., Stange, E. F. and Bevins, C. L. (2005). Reduced Paneth cell α-defensins in ileal Crohn's disease. Proc. Natl. Acad. Sci. USA 102, 18129-18134.
73. Wehkamp, J., Harder, J., Weichenthal, M., Schwab, M., Schaffeler, E., Schlee, M., Herrlinger, K. R., Stallmach, A., Noack, F., Fritz, P., Schroder, J. M., Bevins, C. L., Fellermann, K. and Stange, E. F. (2004). NOD2 (CARD15) mutations in Crohn's disease are associated with diminished mucosal α-defensin expression. Gut 53, 1658-1664.